|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/17 | |||
| A61K 39/39 | |||
| A61K 39/00 | |||
| G01N 33/68 | |||
| A61K 48/00 | |||
| A61P 25/28 | |||
| C07K 14/47 |
| (11) | Number of the document | 2305302 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10183051.1 |
| Date of filing the European patent application | 2000-05-26 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 322289 | 1999-05-28 | US |
| (72) |
Schenk, Dale B., US
Bard, Frederique, US
Vasquez, Nicki J., US
Yednock, Ted, US
|
| (73) |
Janssen Alzheimer Immunotherapy,
Airton Road Tallaght, Dublin 24,
IE
|
| (54) | PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE |
| PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE |